For example, both clinical and preclinical studies suggest that AR signaling is a reversible cause of therapeutic resistance to multiple bladder-cancer-directed therapies including BCG immunotherapy [58], radiation [66], and cisplatin chemotherapy [67,68,69,70]. Here, AR is linked to urinary bladder cancer.